NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS - News), a cell therapy Company dedicated to the commercialization of stem cell products for a variety of indications, today announced that it has signed a binding term sheet with new investors for a private equity investment in the amount of $8,000,000. The first payment of funds totaling $1,250,000 has been received.

ADVERTISEMENT document.write('<a href="http://us.ard.yahoo.com/SIG=12emb52sj/M=559572.9476524.10711531.1383221/D=fin/S=7811759:LREC/Y=YAHOO/EXP=1171465799/A=4312093/R=1/SIG=12kf6963l/*http://clk.atdmt.com/2G0/go/yhxxxfrx00600000262g0/direct/01/?time=1171458599030921" target="_blank"><img src="http://view.atdmt.com/2G0/view/yhxxxfrx00600000262g0/direct/01/?time=1171458599030921"/></a>'); if(window.yzq_d==null)window.yzq_d=new Object(); window.yzq_d['rlpQF0LaX9U-']='&U=13aje4adv%2fN%3drlpQF0LaX9U-%2fC%3d559572.9476524.10711531.1383221%2fD%3dLREC%2fB%3d4312093';

The investors will receive Pluristem restricted common stock at a price of $0.0125 per share and a warrant to purchase additional shares at an exercise price of $0.025 per share. The final agreement is expected to be completed by March 15, 2007.